NUR 265 Exam 2 Actual Exam Prep Document | 2026/2027
Edition | 200 Verified Questions - 150 Questions with Answers
NUR 265 Exam 2 2026-150 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation resource for NUR 265 Exam 2 (Med-Surg Nursing) contains
200 verified questions with answers, covering essential topics in pharmacology, patient care, and
pathophysiology. Designed for nursing students in the 2026/2027 academic year, this document aligns
with current NCLEX-style testing and evidence-based practice. Each question includes a detailed
rationale to reinforce critical thinking and clinical reasoning. This guide is an indispensable tool for
achieving a high score on the exam.
Key Features:
Pharmacology: drug classifications, mechanisms, side effects, and nursing implications
Medical-Surgical Nursing: management of acute and chronic conditions
Patient Care: prioritization, safety, and interdisciplinary collaboration
Pathophysiology: disease processes and their clinical manifestations
NCLEX-style questions with rationales for correct and incorrect options
Updated to reflect 2026/2027 guidelines and best practices
Updates for 2026:
- Revised to include the latest NCLEX-RN test plan updates for 2026-2027
- Incorporated new evidence-based practice guidelines for med-surg nursing
- Enhanced rationales to address common student misconceptions
- Added more pharmacology questions to reflect increased exam emphasis
- Updated patient care scenarios to align with current clinical protocols
Abstract:
This exam preparation document for NUR 265 Exam 2 provides a rigorous review of medical-surgical nursing
concepts essential for nursing students in the 2026/2027 academic year. The content is organized into four major
areas: pharmacology, patient care, pathophysiology, and medical-surgical nursing management. Each of the 200
questions is designed to assess clinical judgment and application of knowledge, with detailed rationales that
explain both correct and incorrect answers. The material reflects the latest evidence-based practices and
NCLEX-RN test plan, ensuring relevance and accuracy. By engaging with this resource, students will deepen their
understanding of complex disease processes, pharmacological interventions, and holistic patient care. The
structured format facilitates systematic study and self-assessment, promoting retention and exam readiness. This
guide is an essential component of a comprehensive study strategy for NUR 265.
Keywords:
NUR 265, Med-Surg Nursing, Pharmacology, Patient Care, Pathophysiology, NCLEX-style questions, Exam prep
2026/2027
Answer Format:
Each question is presented in NCLEX-style format with four answer options. The correct answer is indicated,
followed by a comprehensive rationale explaining why it is correct and why the other options are incorrect.
Rationales include pathophysiological mechanisms, nursing interventions, and pharmacological principles to
enhance learning.
Compliance Checklist:
Aligned with 2026/2027 NCLEX-RN test plan
Page 1
, Updated per latest evidence-based practice guidelines
Verified by nursing educators and clinical experts
Includes rationales for all answer choices
Covers all major content areas of NUR 265 Exam 2
Formatted for easy navigation and study
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacology 1-50 Drug classifications, mechanisms of action, 25%
side effects, nursing implications, drug
interactions
Medical-Surgical Nursing 51-100 Management of acute/chronic conditions, 25%
perioperative care, wound care,
fluid/electrolyte balance
Patient Care 101-150 Prioritization, safety, patient education, 25%
interdisciplinary collaboration, ethical/legal
issues
Pathophysiology 151-200 Disease processes, clinical manifestations, 25%
diagnostic tests, complications
Page 2
,Q1. In a patient with acute decompensated heart failure and preserved ejection
fraction, which hemodynamic principle primarily explains the benefit of using a
vasodilator like nitroprusside over a pure inotrope?
A. Inotropes increase myocardial oxygen demand and worsen ischemia, while
vasodilators reduce preload and afterload without direct inotropic effect
B. Vasodilators improve renal perfusion more effectively than inotropes, leading to
better diuresis
C. Inotropes are contraindicated in HFpEF due to risk of arrhythmia, while vasodilators
have no such risk
D. Vasodilators cause reflex tachycardia, which is beneficial in HFpEF to maintain
cardiac output
Correct Answer: A. Inotropes increase myocardial oxygen demand and worsen
ischemia, while vasodilators reduce preload and afterload without direct inotropic
effect
Rationale: In HFpEF, the problem is impaired relaxation and increased filling pressures,
not systolic failure. Inotropes increase contractility and oxygen demand, potentially
causing ischemia and arrhythmias. Vasodilators reduce preload and afterload, lowering
filling pressures and improving cardiac output without increasing myocardial oxygen
consumption. The other options misrepresent the pharmacology or hemodynamic goals.
Why Wrong:
B - Renal perfusion improvement is not the primary reason; the benefit is reduced
filling pressures and oxygen demand.
C - Inotropes are not absolutely contraindicated in HFpEF; they are used cautiously in
acute decompensation.
D - Reflex tachycardia is generally detrimental, not beneficial, in HFpEF.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q2. A patient with sepsis and acute kidney injury is prescribed vancomycin and
piperacillin-tazobactam. Which pharmacodynamic principle most accurately predicts
the need for therapeutic drug monitoring of vancomycin?
A. Vancomycin exhibits time-dependent killing, so maintaining trough levels above the
MIC is critical
B. Vancomycin exhibits concentration-dependent killing, so peak levels correlate with
efficacy
C. Vancomycin has a post-antibiotic effect that eliminates the need for frequent dosing
D. Vancomycin is primarily hepatically metabolized, so renal function does not affect
its clearance
Correct Answer: A. Vancomycin exhibits time-dependent killing, so maintaining
trough levels above the MIC is critical
Page 3
, Rationale: Vancomycin is a time-dependent antibiotic; its bactericidal activity correlates
with the duration that serum concentrations exceed the MIC. Therefore, trough levels are
monitored to ensure adequate exposure and to minimize nephrotoxicity, especially in
patients with renal impairment. The other options incorrectly describe vancomycin's
pharmacodynamics or metabolism.
Why Wrong:
B - Concentration-dependent killing applies to aminoglycosides, not vancomycin.
C - While vancomycin has a post-antibiotic effect, it does not negate the need for
trough monitoring.
D - Vancomycin is renally eliminated, not hepatically metabolized.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 84
Q3. A patient with chronic obstructive pulmonary disease (COPD) is started on a
long-acting muscarinic antagonist (LAMA). Which physiological effect best explains
the improvement in exercise tolerance?
A. Inhibition of muscarinic receptors reduces vagal tone, leading to bronchodilation
and decreased air trapping
B. Stimulation of beta-2 receptors causes smooth muscle relaxation and increased
cyclic AMP
C. Blockade of histamine receptors reduces airway inflammation and mucus secretion
D. Inhibition of phosphodiesterase-4 decreases inflammation and increases cyclic GMP
Correct Answer: A. Inhibition of muscarinic receptors reduces vagal tone, leading to
bronchodilation and decreased air trapping
Rationale: LAMAs, such as tiotropium, block muscarinic receptors (M3) on airway
smooth muscle, reducing cholinergic-mediated bronchoconstriction. This leads to
bronchodilation, decreased air trapping, and improved exercise tolerance. The other
options describe mechanisms of other drug classes: beta-2 agonists, antihistamines, and
PDE4 inhibitors.
Why Wrong:
B - Beta-2 agonists are SABAs/LABAs, not LAMAs.
C - Histamine blockade is not the primary mechanism of LAMAs.
D - PDE4 inhibitors, like roflumilast, work differently and are not LAMAs.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 74
Q4. A patient with type 2 diabetes and chronic kidney disease (eGFR 30 mL/min) is
prescribed metformin. Which statement accurately reflects the current
recommendation regarding metformin use in this population?
A. Metformin is contraindicated at eGFR < 30, and an alternative agent should be
selected
Page 4
Edition | 200 Verified Questions - 150 Questions with Answers
NUR 265 Exam 2 2026-150 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation resource for NUR 265 Exam 2 (Med-Surg Nursing) contains
200 verified questions with answers, covering essential topics in pharmacology, patient care, and
pathophysiology. Designed for nursing students in the 2026/2027 academic year, this document aligns
with current NCLEX-style testing and evidence-based practice. Each question includes a detailed
rationale to reinforce critical thinking and clinical reasoning. This guide is an indispensable tool for
achieving a high score on the exam.
Key Features:
Pharmacology: drug classifications, mechanisms, side effects, and nursing implications
Medical-Surgical Nursing: management of acute and chronic conditions
Patient Care: prioritization, safety, and interdisciplinary collaboration
Pathophysiology: disease processes and their clinical manifestations
NCLEX-style questions with rationales for correct and incorrect options
Updated to reflect 2026/2027 guidelines and best practices
Updates for 2026:
- Revised to include the latest NCLEX-RN test plan updates for 2026-2027
- Incorporated new evidence-based practice guidelines for med-surg nursing
- Enhanced rationales to address common student misconceptions
- Added more pharmacology questions to reflect increased exam emphasis
- Updated patient care scenarios to align with current clinical protocols
Abstract:
This exam preparation document for NUR 265 Exam 2 provides a rigorous review of medical-surgical nursing
concepts essential for nursing students in the 2026/2027 academic year. The content is organized into four major
areas: pharmacology, patient care, pathophysiology, and medical-surgical nursing management. Each of the 200
questions is designed to assess clinical judgment and application of knowledge, with detailed rationales that
explain both correct and incorrect answers. The material reflects the latest evidence-based practices and
NCLEX-RN test plan, ensuring relevance and accuracy. By engaging with this resource, students will deepen their
understanding of complex disease processes, pharmacological interventions, and holistic patient care. The
structured format facilitates systematic study and self-assessment, promoting retention and exam readiness. This
guide is an essential component of a comprehensive study strategy for NUR 265.
Keywords:
NUR 265, Med-Surg Nursing, Pharmacology, Patient Care, Pathophysiology, NCLEX-style questions, Exam prep
2026/2027
Answer Format:
Each question is presented in NCLEX-style format with four answer options. The correct answer is indicated,
followed by a comprehensive rationale explaining why it is correct and why the other options are incorrect.
Rationales include pathophysiological mechanisms, nursing interventions, and pharmacological principles to
enhance learning.
Compliance Checklist:
Aligned with 2026/2027 NCLEX-RN test plan
Page 1
, Updated per latest evidence-based practice guidelines
Verified by nursing educators and clinical experts
Includes rationales for all answer choices
Covers all major content areas of NUR 265 Exam 2
Formatted for easy navigation and study
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacology 1-50 Drug classifications, mechanisms of action, 25%
side effects, nursing implications, drug
interactions
Medical-Surgical Nursing 51-100 Management of acute/chronic conditions, 25%
perioperative care, wound care,
fluid/electrolyte balance
Patient Care 101-150 Prioritization, safety, patient education, 25%
interdisciplinary collaboration, ethical/legal
issues
Pathophysiology 151-200 Disease processes, clinical manifestations, 25%
diagnostic tests, complications
Page 2
,Q1. In a patient with acute decompensated heart failure and preserved ejection
fraction, which hemodynamic principle primarily explains the benefit of using a
vasodilator like nitroprusside over a pure inotrope?
A. Inotropes increase myocardial oxygen demand and worsen ischemia, while
vasodilators reduce preload and afterload without direct inotropic effect
B. Vasodilators improve renal perfusion more effectively than inotropes, leading to
better diuresis
C. Inotropes are contraindicated in HFpEF due to risk of arrhythmia, while vasodilators
have no such risk
D. Vasodilators cause reflex tachycardia, which is beneficial in HFpEF to maintain
cardiac output
Correct Answer: A. Inotropes increase myocardial oxygen demand and worsen
ischemia, while vasodilators reduce preload and afterload without direct inotropic
effect
Rationale: In HFpEF, the problem is impaired relaxation and increased filling pressures,
not systolic failure. Inotropes increase contractility and oxygen demand, potentially
causing ischemia and arrhythmias. Vasodilators reduce preload and afterload, lowering
filling pressures and improving cardiac output without increasing myocardial oxygen
consumption. The other options misrepresent the pharmacology or hemodynamic goals.
Why Wrong:
B - Renal perfusion improvement is not the primary reason; the benefit is reduced
filling pressures and oxygen demand.
C - Inotropes are not absolutely contraindicated in HFpEF; they are used cautiously in
acute decompensation.
D - Reflex tachycardia is generally detrimental, not beneficial, in HFpEF.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24
Q2. A patient with sepsis and acute kidney injury is prescribed vancomycin and
piperacillin-tazobactam. Which pharmacodynamic principle most accurately predicts
the need for therapeutic drug monitoring of vancomycin?
A. Vancomycin exhibits time-dependent killing, so maintaining trough levels above the
MIC is critical
B. Vancomycin exhibits concentration-dependent killing, so peak levels correlate with
efficacy
C. Vancomycin has a post-antibiotic effect that eliminates the need for frequent dosing
D. Vancomycin is primarily hepatically metabolized, so renal function does not affect
its clearance
Correct Answer: A. Vancomycin exhibits time-dependent killing, so maintaining
trough levels above the MIC is critical
Page 3
, Rationale: Vancomycin is a time-dependent antibiotic; its bactericidal activity correlates
with the duration that serum concentrations exceed the MIC. Therefore, trough levels are
monitored to ensure adequate exposure and to minimize nephrotoxicity, especially in
patients with renal impairment. The other options incorrectly describe vancomycin's
pharmacodynamics or metabolism.
Why Wrong:
B - Concentration-dependent killing applies to aminoglycosides, not vancomycin.
C - While vancomycin has a post-antibiotic effect, it does not negate the need for
trough monitoring.
D - Vancomycin is renally eliminated, not hepatically metabolized.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 84
Q3. A patient with chronic obstructive pulmonary disease (COPD) is started on a
long-acting muscarinic antagonist (LAMA). Which physiological effect best explains
the improvement in exercise tolerance?
A. Inhibition of muscarinic receptors reduces vagal tone, leading to bronchodilation
and decreased air trapping
B. Stimulation of beta-2 receptors causes smooth muscle relaxation and increased
cyclic AMP
C. Blockade of histamine receptors reduces airway inflammation and mucus secretion
D. Inhibition of phosphodiesterase-4 decreases inflammation and increases cyclic GMP
Correct Answer: A. Inhibition of muscarinic receptors reduces vagal tone, leading to
bronchodilation and decreased air trapping
Rationale: LAMAs, such as tiotropium, block muscarinic receptors (M3) on airway
smooth muscle, reducing cholinergic-mediated bronchoconstriction. This leads to
bronchodilation, decreased air trapping, and improved exercise tolerance. The other
options describe mechanisms of other drug classes: beta-2 agonists, antihistamines, and
PDE4 inhibitors.
Why Wrong:
B - Beta-2 agonists are SABAs/LABAs, not LAMAs.
C - Histamine blockade is not the primary mechanism of LAMAs.
D - PDE4 inhibitors, like roflumilast, work differently and are not LAMAs.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 74
Q4. A patient with type 2 diabetes and chronic kidney disease (eGFR 30 mL/min) is
prescribed metformin. Which statement accurately reflects the current
recommendation regarding metformin use in this population?
A. Metformin is contraindicated at eGFR < 30, and an alternative agent should be
selected
Page 4
